Evidence map›Paper›PMID 40833328›Full record

ArticleTranslational vision science & technology2025

Diagnostic Accuracy of 3D Deep Learning Classifiers for Glaucoma Detection: A Comparison of Cross-Domain and Device-Specific Models.

Akram Belghith, Christopher Bowd, Robert N Weinreb, Jalil Jalili, Mark Christopher, Linda M Zangwill

Abstract readComparative Study
In one paragraph

Article in Translational vision science & technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Artificial Intelligence in Glaucoma Detection and Progression.Advances in ophthalmology and optometry · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Akram BelghithHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.
Christopher BowdHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.
Robert N WeinrebHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.
Jalil JaliliHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.
Mark ChristopherHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.
Linda M ZangwillHamilton Glaucoma Center and Division of Ophthalmology Informatics and Data Science, Shiley Eye Institute, The Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA, USA.

Funding

African Descent And Glaucoma Evaluation Study (ADAGES)U10EY014267 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2002 to 2010
$13.2M
Vision BiostatisticsP30EY022589 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2012 to 2026
$10.3M
Diagnostic Innovations in Glaucoma:Structural AssessmentR01EY011008 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 1995 to 2015
$8.7M
xADAGES III: Contribution of genotype to glaucoma phenotype in African AmericansR01EY023704 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROTTER, JEROME I, WEINREB, ROBERT N · 2013 to 2017
$6.3M
Diagnostic Innovations in Glaucoma Study (DIGS): High Myopia and Advanced DiseaseR01EY027510 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LINDA M ZANGWILL · 2017 to 2026
$5.3M
Diagnosis and Monitoring of Glaucoma with Optical Coherence Tomography AngiographyR01EY029058 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI WEINREB, ROBERT N · 2018 to 2024
$4.2M
African Descent and Glaucoma Evaluation (ADAGES) II: Glaucoma ProgressionR01EY019869 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2010 to 2014
$2.8M
African Descent and Glaucoma Evaluation (ADAGES) IV: Alterations of the lamina cribrosa in progressionR01EY026574 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI FAZIO, MASSIMO ANTONIO, GIRKIN, CHRISTOPHER ANTHONY · 2017 to 2020
$2.6M
Multimodal Artificial Intelligence to Predict Glaucomatous Progression and Surgical InterventionR01EY034146 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BAXTER, SALLY LIU, CHRISTOPHER, MARK · 2022 to 2025
$1.8M
Predicting and Detecting Glaucomatous Progression Using Pattern RecognitionR01EY022039 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BOWD, CHRISTOPHER · 2012 to 2015
$1.5M
Deep Learning Approaches to Detect Glaucoma and Predict Progression from Spectral Domain Optical Coherence TomographyR00EY030942 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHRISTOPHER, MARK · 2023 to 2025
$747k
OCT in the Ocular Hypertension Treatment Study: 20 Year Follow-upR21EY031125 · NEI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ZANGWILL, LINDA M · 2020 to 2021
$442k
NEI NIH HHS P30 EY022589NEI NIH HHS R00 EY030942NEI NIH HHS R01 EY011008NEI NIH HHS R01 EY019869NEI NIH HHS R01 EY022039NEI NIH HHS R01 EY023704NEI NIH HHS R01 EY026574NEI NIH HHS R01 EY027510NEI NIH HHS R01 EY029058NEI NIH HHS R01 EY034146NEI NIH HHS R21 EY027945NEI NIH HHS R21 EY031125NEI NIH HHS R41 EY034424NEI NIH HHS U10 EY014267
6 · The paper itself

Abstract

Purpose: To evaluate the accuracy of a three-dimensional (3D) deep learning (3D DL) and 3D cross domain deep learning (3D CD-DL) classifiers compared to standard macular ganglion cell-inner plexiform layer (GCIPL) thickness measurements for classifying eyes with glaucoma using optical coherence tomography (OCT). Methods: A total of 502 primary open-angle glaucoma eyes from 295 patients and 119 healthy eyes from 63 individuals were included. Two classifiers were compared: (1) a 3D DL model trained on Spectralis macular OCT and applied to Spectralis macular OCT images and (2) 3D CD-DL model trained on synthetic Spectralis images generated from 3D Cirrus macular OCT using Cycle-consistent adversarial networks (CycleGAN) and applied to real Spectralis macula OCT images. An additional 100 different eyes (50 Cirrus, 50 Spectralis) were used to train the CycleGAN. Age, axial length, and disc area adjusted area under the receiver operating curves (AUROC) were used to compare model accuracy. Results: Adjusted AUROC for 3D DL model was 0.92 (95% confidence interval [CI], 0.85-0.95). This was significantly higher than global GCIPL thickness (0.83 [0.78-0.85], p ≤ 0.001) but similar to 3D CD-DL (0.91 [0.84-0.95], P = 0.45). Using only early glaucoma eyes (mean deviation ≥ -3.0 dB), the 3D DL model showed significantly higher diagnostic accuracy (0.90 [0.84-0.94]) compared to global GCIPL thickness (0.80 [0.76-0.82], P ≤ 0.001) but similar to the 3D CD-DL model (0.90 [0.83-0.93], P = 0.51). Conclusions: The 3D DL classifier showed significantly higher diagnostic accuracy than global GCIPL thickness but was similar in performance to the 3D CD-DL classifier. By using synthetic data and diverse training sets, cross-domain learning produces robust, generalizable models across different imaging devices as demonstrated by the comparable accuracy of the 3D CD-DL and device-specific 3D DL models. More data from other OCT devices are needed to further validate these findings. Translational Relevance: The 3D Deep learning models significantly surpass traditional GCIPL thickness measurements for accurately detecting glaucoma. The cross-domain model closely matches the performance of the device-specific model in glaucoma classification potentially reducing the need for device-specific models in clinical practice.

Indexed as

Deep LearningGlaucoma, Open-AngleImaging, Three-DimensionalTomography, Optical CoherenceAgedFemaleGlaucomaHumansMaleMiddle AgedRetinal Ganglion CellsROC Curve

Identifiers

PMID40833328
PMCPMC12383880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.